-
August 10, 2016 Lupin Receives FDA Approval for Generic Klor-Con® Extended-Release Tablets
-
August 9, 2016 Record Sales & Profits – Quarter I FY2017
-
August 2, 2016 Lupin Acquires Branded Product Portfolio from Shionogi in Japan
-
July 27, 2016 Lupin Receives Tentative Approval for Generic Lexiva® Tablets, 700 mg from US FDA
-
July 20, 2016 Lupin Launches Generic Ortho Tri-Cyclen® Tablets in the US
-
July 8, 2016 US FDA Audit at Lupin’s Dabhasa Facility, 29th June – 06th July 2016
-
July 7, 2016 Lupin receives EIR from US FDA for Goa, July 2015 Inspection
-
June 22, 2016 Lupin Receives FDA Approval for Generic Activella® Tablets
-
June 7, 2016 Lupin Appoints Yugesh Goutam as President – Global HR
In this section
Media Contacts
-
Rajalakshmi Azariah
Vice President & Global Head – Corporate Communications